Associated Papers
Identification of TARDBP Gly298Ser as a founder mutation for amyotrophic lateral sclerosis in Southern China.
Xu F et al.
Bmc Medical Genomics, 2022
35932023 (PubMed )
Supplement: 12920_2022_1327_MOESM1_ESM.docx
Modelling amyotrophic lateral sclerosis in rodents.
Todd TW et al.
Nature Reviews. Neuroscience, 2022
Molecular Mechanisms Underlying TDP-43 Pathology in Cellular and Animal Models of ALS and FTLD.
Wood A et al.
International Journal of Molecular Sciences, 2021
Pathogenic Genome Signatures That Damage Motor Neurons in Amyotrophic Lateral Sclerosis.
Yousefian-Jazi A et al.
Cells, 2020
Endoplasmic Reticulum Stress and Unfolded Protein Response in Neurodegenerative Diseases.
Ghemrawi R et al.
International Journal of Molecular Sciences, 2020
Disrupted neuronal trafficking in amyotrophic lateral sclerosis.
Burk K et al.
Acta Neuropathologica, 2019
The debated toxic role of aggregated TDP-43 in amyotrophic lateral sclerosis: a resolution in sight?
Hergesheimer RC et al.
Brain : a Journal of Neurology, 2019
30938443 (PubMed )
Supplement: awz078_supplementary_data.pdf
From animal models to human disease: a genetic approach for personalized medicine in ALS.
Picher-Martel V et al.
Acta Neuropathologica Communications, 2016
Emerging mechanisms of molecular pathology in ALS.
Peters OM et al.
The Journal of Clinical Investigation, 2015
Downregulation of VAPB expression in motor neurons derived from induced pluripotent stem cells of ALS8 patients.
Mitne-Neto M et al.
Human Molecular Genetics, 2011
Select a paper to view details